Status:
COMPLETED
Physical Activity Post COVID-19
Lead Sponsor:
University of Alcala
Collaborating Sponsors:
Professional College of Physiotherapists of the Community of Madrid (CPFCM)
University Hospital of Guadalajara (HUGU)
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
THis study aims to examine PA trajectory, and potential behaviour-change factors least 12 months after COVID-19, across different levels of acute disease severity, and specifically in people with and ...
Detailed Description
Eligible participants will be contacted and invited for a first visit by a pulmonologist or a respiratory physiotherapist, during which those interested will provide informed consent. Participants wil...
Eligibility Criteria
Inclusion
- At least, 18 years of age;
- Diagnosis with COVID-19;
- Stable condition at hospital discharge or after 21 days of being treated at home (needed time to recover from an acute respiratory infection; however, patients treated at home should report a negative result in polymerase chain reaction \[PCR\] test).
- Those reporting clinically relevant symptoms among dyspnoea, fatigue, anxiety, depression or impaired health-related quality of life will be considered affected from post-COVID-19 condition or Long COVID.
Exclusion
- Presence of signs of cognitive impairment or significant cardiovascular, neurological, and/or musculoskeletal disease, which may prevent the assessment tests and therefore limit participation. In particular, reasons for exclusion will be the following: cognitive disorders, such as sequelae of Alzheimer's disease, senile dementia; comprehension disorders, such as Wernicke's aphasia; cognitive-motor disorders, such as hemiparesis/hemiplegia due to stroke; musculoskeletal disorders, such as unconsolidated fractures, external prostheses (including replacements in amputees); cardiovascular disorders, such as unstable angina, recent acute myocardial infarction, among others.
- Vacination before infection.
- Reinfections during follow-up.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT04768257
Start Date
May 1 2021
End Date
December 1 2023
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Guadalajara
Guadalajara, Castille-La Mancha, Spain, 19002